Rosenblatt has acted for Revelan Holdings Limited and the wider Revelan Group, a group of property investment and development companies, in connection with a sale by one of the Founding Partners coupled with an equity investment by Geranium Holdings Sarl in Revelan Holdings Limited, a share and group reorganisation, bonus issue and redemption of loan notes, together with the putting in place of intra-group subordinated loans, a put and call option and effecting changes to directorships within the Revelan Group. The Rosenblatt team provided both corporate and banking advice in relation to the transaction which successfully completed on 6 October 2017.
The Rosenblatt team was led by Jon Lovitt (Corporate Partner) who was assisted by Sophie Lang (Corporate Solicitor), David Sachs (Head of Banking), Tom Driscoll (Banking Solicitor) and Verity Ingle (Trainee Solicitor).
Funding for ovarian cancer research has dropped by a third in the past five years. This comes at a time of a projected rise in the incidence rates of the disease, meaning UK women are facing a demographic ‘time bomb’ in ovarian cancer. Target Ovarian Cancer’s new campaign launching today, says enough is enough. It’s time to TAKE OVAR.